Jefferies Downgrades AcelRx Pharmaceuticals To Hold
March 10, 2015 at 09:29 AM EDT
Analysts at Jefferies downgraded AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) from Buy to Hold. The price target for AcelRx ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.